RxDoctor Payments Data

Sondra Smith

Nurse Practitioner · Homestead, FLNPI 1164759957

Payments from drug & device makers

$3,762in general payments, 2019–2025

Across 183 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$673
  • AstraZeneca$436
  • Lilly USA, LLC$380
  • Novo Nordisk$275
  • Exact Sciences$114
  • plus $386 from 10 others

What the payments were for

  • Food & beverage$3,762100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,762 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide51$64,640
OzempicSemaglutide40$63,596
EliquisApixaban44$61,450
JardianceEmpagliflozin50$55,443
FarxigaDapagliflozin Propanediol48$44,363
Breztri AerosphereBudesonide/Glycopyr/Formoterol45$39,536
TrulicityDulaglutide29$37,567
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$28,298
QuliptaAtogepant15$20,225
VraylarCariprazine Hcl12$17,190
MyrbetriqMirabegron11$14,140
Repatha SureclickEvolocumab12$13,044
Emgality PenGalcanezumab-Gnlm13$10,658
SymbicortBudesonide/Formoterol Fumarate21$8,045
Albuterol Sulfate HfaAlbuterol Sulfate122$6,439

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Insulin Lispro$380$103,14292 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$436$91,944114 claims
Novo NordiskOzempic$275$63,59640 claims
PfizerEliquis$36$61,45044 claims
AbbVieQulipta, Vraylar, Synthroid$1,497$38,24743 claims
GSKTrelegy Ellipta, Anoro Ellipta$16$33,91830 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Homestead

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →